AACR Award Targets Younger Ca Researchers

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 10
Volume 4
Issue 10

PHILADELPHIA-The American Association for Cancer Research (AACR) is sponsoring its fourth annual Gertrude Elion Cancer Research Award. This award, provided through an educational grant from Glaxo Wellcome Oncology, is open to nontenured cancer investigators in clinical, basic, or translational research in the United States and Canada.

PHILADELPHIA-The American Association for Cancer Research (AACR)is sponsoring its fourth annual Gertrude Elion Cancer ResearchAward. This award, provided through an educational grant fromGlaxo Wellcome Oncology, is open to nontenured cancer investigatorsin clinical, basic, or translational research in the United Statesand Canada.

The application deadline is February 15, 1996, and the award willbe presented at the AACR annual meeting in Washington, DC, inApril, 1996.

The award recipient must have completed postdoctoral studies orclinical fellowships no later than July 1, 1996, and ordinarilynot more than 5 years prior to the award year. The 1-year awardincludes a $30,000 grant plus travel to the AACR annual meeting.

For more information, contact Jenny Anne Horst-Martz at the AACRin Philadelphia. Phone: 215-440-9300; Email: aacr@aol.com.

Recent Videos
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content